Inger Björn

715 total citations
13 papers, 442 citations indexed

About

Inger Björn is a scholar working on Public Health, Environmental and Occupational Health, Endocrinology, Diabetes and Metabolism and Reproductive Medicine. According to data from OpenAlex, Inger Björn has authored 13 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 8 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Reproductive Medicine. Recurrent topics in Inger Björn's work include Menopause: Health Impacts and Treatments (7 papers), Menstrual Health and Disorders (6 papers) and Estrogen and related hormone effects (3 papers). Inger Björn is often cited by papers focused on Menopause: Health Impacts and Treatments (7 papers), Menstrual Health and Disorders (6 papers) and Estrogen and related hormone effects (3 papers). Inger Björn collaborates with scholars based in Sweden and United States. Inger Björn's co-authors include Marie Bixo, Inger Sundström Poromaa, Sigrid Nyberg, Monica Åström, Torbjörn Bäckström, Owe Johnson, Mats Eliasson, Anders Larsson, Pål Wölner‐Hanssen and Mingde Wang and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, American Journal of Obstetrics and Gynecology and Fertility and Sterility.

In The Last Decade

Inger Björn

12 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inger Björn Sweden 10 216 182 99 87 85 13 442
Beth A. Prairie United States 10 209 1.0× 142 0.8× 56 0.6× 51 0.6× 73 0.9× 14 487
Hristina Koleva United States 8 237 1.1× 146 0.8× 52 0.5× 50 0.6× 51 0.6× 9 428
E. S. Mitchell United States 12 179 0.8× 261 1.4× 94 0.9× 99 1.1× 45 0.5× 14 450
Gioia M. Guerrieri United States 8 100 0.5× 130 0.7× 65 0.7× 61 0.7× 62 0.7× 10 320
Anne Mariella United States 6 312 1.4× 325 1.8× 109 1.1× 147 1.7× 79 0.9× 6 556
K. Lih‐Mei Liao United Kingdom 9 131 0.6× 336 1.8× 128 1.3× 106 1.2× 18 0.2× 12 502
Beverley Ayers United Kingdom 9 134 0.6× 386 2.1× 165 1.7× 57 0.7× 22 0.3× 12 539
A. Oldenhave Netherlands 6 94 0.4× 312 1.7× 174 1.8× 122 1.4× 19 0.2× 7 488
Leyla Gülseren Türkiye 9 76 0.4× 210 1.2× 32 0.3× 57 0.7× 19 0.2× 22 515
Lara Tiranini Italy 12 169 0.8× 251 1.4× 51 0.5× 110 1.3× 18 0.2× 34 646

Countries citing papers authored by Inger Björn

Since Specialization
Citations

This map shows the geographic impact of Inger Björn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inger Björn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inger Björn more than expected).

Fields of papers citing papers by Inger Björn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inger Björn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inger Björn. The network helps show where Inger Björn may publish in the future.

Co-authorship network of co-authors of Inger Björn

This figure shows the co-authorship network connecting the top 25 collaborators of Inger Björn. A scholar is included among the top collaborators of Inger Björn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inger Björn. Inger Björn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bixo, Marie, Inger Björn, Pål Wölner‐Hanssen, et al.. (2008). Effect of Sibutramine on Weight Reduction in Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Obstetrical & Gynecological Survey. 63(11). 707–709. 3 indexed citations
2.
Bixo, Marie, Inger Björn, Pål Wölner‐Hanssen, et al.. (2007). Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Fertility and Sterility. 89(5). 1221–1228. 31 indexed citations
3.
Bixo, Marie, et al.. (2006). Patients with psychiatric disorders in gynecologic practice—a three year follow-up. Journal of Psychosomatic Obstetrics & Gynecology. 27(1). 17–22. 8 indexed citations
4.
Björn, Inger, Torbjörn Bäckström, Ann Lalos, & Inger Sundström Poromaa. (2006). Adverse mood effects during postmenopausal hormone treatment in relation to personality traits. Climacteric. 9(4). 290–297. 9 indexed citations
5.
Björn, Inger, et al.. (2003). Increase of Estrogen Dose Deteriorates Mood during Progestin Phase in Sequential Hormonal Therapy. The Journal of Clinical Endocrinology & Metabolism. 88(5). 2026–2030. 53 indexed citations
6.
Björn, Inger, et al.. (2002). The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Gynecological Endocrinology. 16(1). 1–8.
7.
Björn, Inger, et al.. (2002). The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy. Gynecological Endocrinology. 16(1). 1–8. 51 indexed citations
8.
Bixo, Marie, Inger Sundström Poromaa, Inger Björn, & Monica Åström. (2001). Patients with psychiatric disorders in gynecologic practice. American Journal of Obstetrics and Gynecology. 185(2). 396–402. 33 indexed citations
9.
Poromaa, Inger Sundström, Marie Bixo, Inger Björn, & Monica Åström. (2001). Prevalence of psychiatric disorders in gynecologic outpatients. American Journal of Obstetrics and Gynecology. 184(2). 8–13. 49 indexed citations
10.
Wang, Mingde, Inger Sundström Poromaa, Göran Wahlström, et al.. (2001). Neuroactive steroids and central nervous system disorders. International review of neurobiology. 46. 421–459. 38 indexed citations
11.
Poromaa, Inger Sundström, et al.. (2000). Compliance to antidepressant drug therapy for treatment of premenstrual syndrome. Journal of Psychosomatic Obstetrics & Gynecology. 21(4). 205–211. 42 indexed citations
12.
Björn, Inger, et al.. (2000). Negative mood changes during hormone replacement therapy: A comparison between two progestogens. American Journal of Obstetrics and Gynecology. 183(6). 1419–1426. 64 indexed citations
13.
Björn, Inger, et al.. (1999). Drug related negative side-effects is a common reason for poor compliance in hormone replacement therapy. Maturitas. 32(2). 77–86. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026